Therapeutic-Dose Heparin Lowers Risk For Blood Clots, Death In Patients Hospitalized With COVID-19, Study Finds

October 29, 2021

Healio (10/28, Southall) reports, “Therapeutic-dose low-molecular-weight heparin decreased the likelihood of blood clots and death compared with standard of care among patients hospitalized with COVID-19, according to” a study. The results were published...